1/25/2012

The proton pump inhibitor lansoprazole was no better than placebo for improving asthma control and quality of life among children with asthma who had no overt gastroesophageal reflux, a study in the Journal of the American Medical Association found. Researchers also reported that the drug was linked with more respiratory infections.

Related Summaries